These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 8973623)

  • 1. Treatment with Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats.
    Papalois AE; Barbatis C; Chrysikos D; Korontzi M; Sideris M; Pittaras T; Triantafyllidi E; Nomikos A; Triantafillidis JK
    Biomed Res Int; 2019; 2019():8298192. PubMed ID: 31687401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune/Inflammatory Response and Hypocontractility of Rabbit Colonic Smooth Muscle After TNBS-Induced Colitis.
    Zhang Y; Li F; Wang H; Yin C; Huang J; Mahavadi S; Murthy KS; Hu W
    Dig Dis Sci; 2016 Jul; 61(7):1925-40. PubMed ID: 26879904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of resveratrol-induced CD11b(+) Gr-1(+) myeloid derived suppressor cells (MDSCs) in the reduction of CXCR3(+) T cells and amelioration of chronic colitis in IL-10(-/-) mice.
    Singh UP; Singh NP; Singh B; Hofseth LJ; Taub DD; Price RL; Nagarkatti M; Nagarkatti PS
    Brain Behav Immun; 2012 Jan; 26(1):72-82. PubMed ID: 21807089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL).
    Franke A; Balschun T; Sina C; Ellinghaus D; Häsler R; Mayr G; Albrecht M; Wittig M; Buchert E; Nikolaus S; Gieger C; Wichmann HE; Sventoraityte J; Kupcinskas L; Onnie CM; Gazouli M; Anagnou NP; Strachan D; McArdle WL; Mathew CG; Rutgeerts P; Vermeire S; Vatn MH; ; Krawczak M; Rosenstiel P; Karlsen TH; Schreiber S
    Nat Genet; 2010 Apr; 42(4):292-4. PubMed ID: 20228798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatment options in the management of IBD - focus on colony stimulating factors.
    Barahona-Garrido J; Yamamoto-Furusho JK
    Biologics; 2008 Sep; 2(3):501-4. PubMed ID: 19707380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factors as treatment for inflammatory bowel disease: a concise review of the evidence toward their potential clinical utility.
    Barahona-Garrido J; Hernández-Calleros J; García-Juárez I; Yamamoto-Furusho JK
    Saudi J Gastroenterol; 2009; 15(3):208-12. PubMed ID: 19636186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Crohn's disease with colony-stimulating factors: An overview.
    Guidi L; Mocci G; Marzo M; Rutella S
    Ther Clin Risk Manag; 2008 Oct; 4(5):927-34. PubMed ID: 19209275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward improving mucosal barrier defenses: rhG-CSF plus IgG antibody.
    Simmonds A; LaGamma EF
    Indian J Pediatr; 2006 Nov; 73(11):1019-26. PubMed ID: 17127785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory bowel disease-like colitis in glycogen storage disease type 1b.
    Yamaguchi T; Ihara K; Matsumoto T; Tsutsumi Y; Nomura A; Ohga S; Hara T
    Inflamm Bowel Dis; 2001 May; 7(2):128-32. PubMed ID: 11383585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of recombinant granulocyte colony-stimulating factor (rhG-CSF) in experimental colitis.
    Hommes DW; Meenan J; Dijkhuizen S; Ten Kate FJ; Tytgat GN; Van Deventer SJ
    Clin Exp Immunol; 1996 Dec; 106(3):529-33. PubMed ID: 8973623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
    Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
    Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of the inflammatory response in an animal colitis model by neutrophil inhibitory factor, a novel beta 2-integrin antagonist.
    Meenan J; Hommes DW; Mevissen M; Dijkhuizen S; Soule H; Moyle M; Büller HR; ten Kate FW; Tytgat GN; van Deventer SJ
    Scand J Gastroenterol; 1996 Aug; 31(8):786-91. PubMed ID: 8858748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis.
    Opal SM; Jhung JW; Keith JC; Goldman SJ; Palardy JE; Parejo NA
    Blood; 1999 May; 93(10):3467-72. PubMed ID: 10233899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human granulocyte colony-stimulating factor reduces colonic epithelial cell apoptosis and ameliorates murine dextran sulfate sodium-induced colitis.
    Kudo T; Matsumoto T; Nakamichi I; Yada S; Esaki M; Jo Y; Ohji Y; Yao T; Iida M
    Scand J Gastroenterol; 2008; 43(6):689-97. PubMed ID: 18569986
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.